Description
A minor metabolite of the oligomycin complex that is active against Gram-positive bacteria and demonstrates strong antitumor activity against HeLa cells (IC50 = 14 ng/ml)
Formal name: (1R,2’S,4E,5’S,6S,6’S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28R,29R)-22-ethyl-5′,6′-dihydro-7,11,14,15,28-pentahydroxy-6′-[(2R)-2-hydroxypropyl]-5′,6,8,10,12,14,16,28,29-nonamethyl-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2′-[2H]pyran]-3,3′,9,13(4’H)-tetrone
Synonyms: 26-hydroxy-28-oxo-Oligomycin A
Molecular weight: 821.1
CAS: 110231-34-0
Purity: ≥95%
Formulation: A lyophilisate
Product Type|Biochemicals|Antibiotics|Macrolides||Product Type|Biochemicals|Antifungals||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Research Area|Cancer||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Fungal Diseases